Innovations in biopharmaceutical manufacturing will be highlighted with examples from GSK’s manufacturing technology development portfolio of projects. This will include continuous manufacturing of mAbs and a new continuous manufacturing platform for sterile product manufacture. Recent reflections of supply chain disruptions and solutions implemented due to COVID-19 will also be described.
Senior Vice President, Medicine Development and Supply,
Credits: None available.
You must be logged in and own this session in order to